Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Chemomab Therapeutics Ltd. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 16 | 17 | +1 |
| Shares | 4.16M | 3.73M | −429.0K (−10.3%) |
| Value | $7.53M | $4.07M | −$3.46M (−46.0%) |
New holders (1)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 22,104 | $24.1K | 0.00% |
Sold out (0)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q4 2024 and filed for Q1 2025 without it.
None.